01 August 2013

BB Biotech Ventures sell shares in swiss smile Schweiz AG

EQT Partners AB, the Sweden based private equity firm, sells an undisclosed stake in swiss smile Schweiz AG, the Switzerland based chain of dental clinics, for a consideration of CHF 44m (EUR 35.73m). VISCHER advises the seller BB Biotech Ventures G.P., managed by Bellevue Asset Management AG, Switzerland.
The VISCHER team includes Matthias
Staehelin (Partner) and Marius Meier (Associate).

Share article on:

Service(s) included:

Get in touch with our authors and benefit from their expertise:

partner-Matthias-0

Matthias Staehelin

matthias.staehelin@vischer.com

+41 58 211 33 53

Our
newsletter

BB Biotech Ventures sell shares in swiss smile Schweiz AG